CARB-X backs HelixBind to develop sepsis test | FierceBiotech
Mar 21, 2018 @ 12:18

HelixBind has secured funding to develop a blood test for infections linked to sepsis. Antibiotic R&D funding partnership CARB-X is putting up the cash to cut the time it takes to learn what pathogen is responsible for a case of sepsis.

Sourced through from:

Leave a Reply